SCHEMBL21824008

SCHEMBL21824008

Cc1nc(-c2cnc3n(c2=O)CCC(C)N3)ccc1Oc1ccnc(-c2cnn(C)c2)c1

nearest known ligand 0.65

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 20/20 0.65
▸ PDGFRB P09619 7/20 0.65
▸ PDGFRA P16234 12/20 0.62
▸ FLT3 P36888 5/20 0.62
▸ KDR P35968 2/20 0.62
▸ KIT P10721 2/20 0.62
▸ LCK P06239 1/20 0.62
▸ CYP2C9 P11712 1/20 0.62
▸ PTK6 Q13882 1/20 0.62
▸ MET P08581 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21824006 1.00 CSF1R (0.65) CSF1RPDGFRBPDGFRAFLT3KDR
SCHEMBL30673539 1.00 CSF1R (0.65) CSF1RPDGFRBPDGFRAFLT3KDR
SCHEMBL21824024 0.86 CSF1R (0.67) CSF1RPDGFRBPDGFRAFLT3KDR
SCHEMBL30673544 0.86 CSF1R (0.67) CSF1RPDGFRBPDGFRAFLT3KDR
SCHEMBL21824035 0.86 CSF1R (0.66) CSF1RPDGFRBPDGFRAFLT3KDR
SCHEMBL21824020 0.83 CSF1R (0.68) CSF1RPDGFRBPDGFRAFLT3KDR
SCHEMBL21851723 0.82 CSF1R (0.64) CSF1RPDGFRBPDGFRAFLT3KDR
SCHEMBL21824031 0.82 CSF1R (0.64) CSF1RPDGFRBPDGFRAFLT3KDR
SCHEMBL21824034 0.81 CSF1R (0.69) CSF1RPDGFRBPDGFRAFLT3KDR
SCHEMBL31741155 0.81 CSF1R (0.78) CSF1RPDGFRBPDGFRAFLT3KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3632906-B1 AZAARYL DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF FOR USE IN PHARMACY ABBISKO THERAPEUTICS CO LTD (CN) 2023-12-13 — — EP disclosed
EP-3632906-A1 AZAARYL DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF FOR USE IN PHARMACY Abbisko Therapeutics Co., Ltd. (CN) 2020-04-08 — — EP disclosed
Send feedback